CRISPR Point Mutation iPSC Service

SKU :
ASC-6013-3
Catalog # :
ASC-6013-3
Inquire
Questions ? Contact Us
Overview

Point Mutation Cell Lines mimic mutations seen in clinical specimens and are important in vitro disease models to understand role of genes in diseases (immuno-oncology, autoimmune diseases) as well as for drug discovery and immunotherapy development.

Leverage Applied StemCell unique expertise in CRISPR iPSC/ ES Cell Genome Editing Service to generate a point mutation iPSC line in your gene of interest:

Also available, downstream iPSC differentiation and characterization services.

  • Optimized CRISPR protocols for high success rate
  • Homozygous/ heterozygous point mutation clones
  • Footprint-free, feeder-free transfection and iPSC culture protocols
  • Isogenic control lines for reliable experiments

Workflow includes:

  • Cell line evaluation
  • gRNA design, CRISPR vector and donor DNA construction, and reagent validation
  • Transfection of targeting vectors and optimization
  • Screening for single cell clones and clone confirmation
  • Cell expansion and cryopreservation

Deliverables:

  • Two (2) clones for targeted point mutation, with two (2) vials of each clone at 1 x 10^6 cells/vial.
  • Project Milestones Reports, as well as a Final Report containing details of targeting design, experimental, and genotyping results.

Timeline: 3-4 months

Applications:

  • Physiologically relevant disease models for hard-to-model diseases (Ex. ALS, muscular dystrophy, Parkinson's disease, Alzheimer's)
  • Differentiate to study mutations in different tissue lineages with an isogenic panel of cell line models
  • Ideal for target drug discovery, drug and toxicity screening